Instruction for use: Oxylidin solution for injections

Dosage form: solution for injection

Active substance: Benzoclidine*

ATX

N05C Sleeping and sedatives

Pharmacological group:

Anxiolytics

The nosological classification (ICD-10)

F41.2 Mixed anxiety and depressive disorder: Depression with anxiety-depressive components; Mixed anxiety-depressive conditions; Anxiety Depression; Anxious and depressing mood; Anxiety-depressive state; Anxious-depressive conditions; Anxiety-depressive syndrome; Anxious-Neurotic Conditions

F60 Specific personality disorders

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I47.1 Nadzheludochkovaya tachycardia: Nadzheludochkovaya paroxysmal tachycardia; Nadzheludochkovaya tachyarrhythmia; Nadzheludochkovaya tachycardia; Nadzheludochkovye rhythm disturbances; Supraclavicular paroxysmal tachycardia; Nadzheludochkovye tachyarrhythmias; Nadzheludochkovye tachycardias; Neurogenic sinus tachycardia; Orthodontic tachycardia; Paroxysmal supraventricular tachycardia; Paroxysm of supraventricular tachycardia; Paroxysm of supraventricular tachycardia with WPW syndrome; Paroxysm of atrial tachycardia; Paroxysmal supraventricular tachyarrhythmia; Paroxysmal supraventricular tachycardia; Polyotopic atrial tachycardia; Atrial arrhythmia; Atrial True Tachycardia; Atrial tachycardia; Atrial tachycardia with AV blockade; Reperfusion Arrhythmia; The Berzold-Jarish Reflex; Recurrent persistent supraventricular paroxysmal tachycardia; Symptomatic ventricular tachycardia; Sinus tachycardia; Supraventricular paroxysmal tachycardia; Supraventricular tachyarrhythmia; Supraventricular tachycardia; Supraventricular extrasystole; Supraventricular arrhythmias; Tachycardia from the AV joint; Tachycardia supraventricular; Orthodordic tachycardia; Sinus tachycardia; Nodular tachycardia; Chaotic polyotopic atrial tachycardia; Wolff-Parkinson-White syndrome

I63 Cerebral infarction: ischemic Stroke; Ischemic brain disease; Ischemic stroke; Ischemic stroke and its consequences; Ischemic cerebral stroke; Ischemic cerebrovascular accident; Ischemic brain damage; Ischemic brain damage; ischemic conditions; Cerebral ischemia; Acute hypoxia brain; Acute cerebral ischemia; Acute ischemic cerebrovascular accident; Acute cerebral infarction; Acute ischemic stroke; Acute period of ischemic stroke; Focal cerebral ischemia; Ischemic stroke; recurrent stroke; The syndrome of Morgagni-Adams-Stokes; Chronic cerebral ischemia; cerebrovascular stroke; embolic stroke; Ischemic brain damage

Composition and release form

1 ml of solution for injection contains benzo-clidine 0,02 or 0,05 g; In ampoules of 1 ml, in a package of 10 pcs.

Pharmachologic effect

Mode of action - antihypertensive, anxiolytic, sedative.

It reduces the lability of cortical neurons inhibits the activating influence of the reticular formation of the brain stem on its bark.

Pharmacodynamics

Reduces the excitability of the central nervous system, enhances the effect of narcotic hypnotics, analgesics and local anesthetics, has a moderate antihypertensive effect due sedative, adrenolytic and ganglioblokiruyuschim moderate effect, reduces the excitability of vasomotor centers, possesses antiarrhythmic activity.

Indications for the drug Oxylidin solution for injections

Anxiety and depression, neuroses, psychopathy, tsiklogenemiya, hypertension, cerebrovascular accident, hypertensive crisis, sinus tachycardia, paroxysmal tachycardia.

Contraindications

Pronounced hypotension, impaired renal function.

Side effects

Dry mouth, mild nausea, a feeling of mild intoxication, rarely - skin rashes.

Dosing and Administration

SC, IV. First - 2 ml of a 2% solution, then (if necessary, e.g., hypertensive crisis) - 2.1 ml of 5% solution, 2 times a day for 15-30 days or more.

Storage conditions of the drug Oxylidin solution for injections

In the dark place.

Keep out of the reach of children.

Shelf life of the drug Oxylidin solution for injections

2 years.

Do not use after the expiry date printed on the package.